MAYWOOD, Ill.—Güliz A. Barkan, MD, a genitourinary pathologist, and the director of cytopathology and the cytopathology fellowship program at Loyola University Medical Center, has been named president of the American Society of Cytopathology (ASC). Dr. Barkan, who also is a professor at Loyola University Chicago Stritch School of Medicine, will be inaugurated as the 69th president of ASC on November 7, 2020 during ASC’s 68th Annual Scientific Meeting.
Dr. Barkan received her medical degree from Marmara University School of Medicine in Istanbul, Turkey in 1995. She completed residency in anatomic and clinical pathology at the University of Michigan in 2001, and a surgical pathology fellowship there in 2002. She also completed a cytopathology fellowship at the University of Texas M.D. Anderson Cancer Center in 2003. She joined the Loyola University Medical Center department of pathology and laboratory medicine in January 2006. Her interests include cytopathology and surgical pathology of the genitourinary tract, and pathology education. She has authored a significant number of peer-reviewed publications, abstracts, chapters, and given numerous national and international invited talks and workshops, mostly in the fields of cytopathology and surgical pathology of the genitourinary system.
“Dr. Barkan is an exemplary cytopathologist, who will be an outstanding ASC president,” said Eva Wojcik, MD, chair of Loyola’s department of pathology and laboratory medicine, which performs millions of tests at more than 75 inpatient and outpatient clinical service locations. Dr. Wojcik was ASC president in 2015. Loyola is one of a very few institutions in the country to be a home of two ASC presidents, particularly within such a short period of time.
The ASC, founded in 1951, is a distinguished national professional society of physicians, cytotechnologists and scientists who are dedicated to the detection and early diagnosis of nearly all forms of cancer. The ASC is the largest medical society solely devoted to recognizing cellular abnormalities in order to benefit patients. The ASC’s diverse membership of more than 3,000 individuals includes representatives from other countries who share a vision of education, research and continuous improvement in the standards and quality of patient care. The ASC is a unique society that provides a forum where physicians and cytotechnologists can interact and network with each other on both a personal and professional level. For more information on ASC, visit cytopathology.org.